Quanterix (QTRX) Net Cash Flow Growth (1y) (2018 - 2026)
Quanterix (QTRX) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 57.36% |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn | -66.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.33% |
| Dec 31, 2025 | -130.32% |
| Sep 30, 2025 | -421.01% |
| Jun 30, 2025 | 3,189.86% |
| Mar 31, 2025 | 114.73% |
| Dec 31, 2024 | 202.76% |
| Sep 30, 2024 | 85.93% |
| Jun 30, 2024 | 369.81% |
| Mar 31, 2024 | -1,268.48% |
| Dec 31, 2023 | -450.53% |
| Sep 30, 2023 | -609.25% |
| Jun 30, 2023 | 102.83% |
| Mar 31, 2023 | 56.42% |
| Dec 31, 2022 | 62.08% |
| Sep 30, 2022 | 8.95% |
| Jun 30, 2022 | -7.02% |
| Mar 31, 2022 | -108.25% |
| Dec 31, 2021 | -258.85% |
| Sep 30, 2021 | -123.50% |
| Jun 30, 2021 | -53.99% |